SARC Lab

Publications

adobe-pdf-logo

Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas.
Joyner DE, Jones KB, Lessnick SL, Schiffman JD, Randall RL.
Sarcoma. 2011;2011:847409.

Potential for functional redundancy in EGF and TGFalpha signaling in desmoid cells: a cDNA microarray analysis.
Trang SH, Joyner DE, Damron TA, Aboulafia AJ, Randall RL.
Growth Factors. 2010 Feb;28(1):10-23.

adobe-pdf-logo

Desmoid cell motility is induced in vitro by rhEGF.
Joyner DE, Trang SH, Damron TA, Aboulafia AJ, Cummings JE, Randall RL.
J Orthop Res. 2009 Sep;27(9):1258-62.

FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.
Joyner DE, Trang SH, Aboulafia AJ, Damron TA, Randall RL.
Fam Cancer. 2009;8(4):569-80.

adobe-pdf-logo

Fas death pathway in sarcomas correlates with epidermal growth factor transcription.
Joyner DE, Aboulafia AJ, Damron TA, Randall RL.
Clin Orthop Relat Res. 2008 Sep;466(9):2092-8.

Oncogene coexpression in mesenchymal neoplasia correlates with EGF transcription.
Joyner DE, Damron TA, Aboulafia AJ, Randall RL.
Clin Orthop Relat Res. 2007 Jun;459:14-21.

adobe-pdf-logo

Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia.
Joyner DE, Damron TA, Aboulafia A, Bokor W, Bastar JD, Randall RL.
Tissue Antigens. 2006 Jul;68(1):19-27.

adobe-pdf-logo

Doxorubicin induces cell senescence preferentially over apoptosis in the FU-SY-1 synovial sarcoma cell line.
Joyner DE, Bastar JD, Randall RL.
J Orthop Res. 2006 Jun;24(6):1163-9.

adobe-pdf-logo

G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
Joyner DE, Albritton KH, Bastar JD, Randall RL.
J Orthop Res. 2006 Mar;24(3):474-80.

Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing.
Randall RL, Damron TA, Coffin CM, Bastar JD, Joyner DE.
Clin Orthop Relat Res. 2005 Sep;438:149-57.

Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.
Joyner DE, Wade ML, Szabo A, Bastar J, Coffin CM, Albritton KH, Bernard PS, Randall RL.
J Cancer Res Clin Oncol. 2005 Mar;131(3):137-46.

Retrieval yield of total and messenger RNA in mesenchymal tissue ex vivo.
Randall RL, Wade M, Albritton K, Joyner D.
Clin Orthop Relat Res. 2003 Oct;(415):59-63.

Validation of cDNA microarray analysis to distinguish tumor type ex vivo.
Randall RL, Wade M, Albritton KH, Coffin CM, Joyner DE.
Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S110-9.